Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers
- DOI
- 10.1007/s11912-026-01842-y
- Published
- 2026-10-14
- Container
- Current Oncology Reports
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11912-026-01842-y,
title = {Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers},
author = {Daynara da Silva Pereira Lima and Marcelly da Silveira Silva and Moisés da Rocha Soares and Lucas Evangelista Lima Terceiro and Natanael Teles Ramos de Lima and Genil Dantas de Oliveira and Thalisson Amorim de Souza and Valnês Silva Rodrigues-Junior and Samuel Paulo Cibulski},
year = {2026},
journal = {Current Oncology Reports},
doi = {10.1007/s11912-026-01842-y},
url = {https://doi.org/10.1007/s11912-026-01842-y}
}RIS
TY - JOUR TI - Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers AU - Daynara da Silva Pereira Lima AU - Marcelly da Silveira Silva AU - Moisés da Rocha Soares AU - Lucas Evangelista Lima Terceiro AU - Natanael Teles Ramos de Lima AU - Genil Dantas de Oliveira AU - Thalisson Amorim de Souza AU - Valnês Silva Rodrigues-Junior AU - Samuel Paulo Cibulski PY - 2026 JO - Current Oncology Reports DO - 10.1007/s11912-026-01842-y UR - https://doi.org/10.1007/s11912-026-01842-y ER -
APA
Lima, D. D. S. P., Silva, M. D. S., Soares, M. D. R., Terceiro, L. E. L., Lima, N. T. R. D., Oliveira, G. D. D., Souza, T. A. D., Rodrigues-Junior, V. S., & Cibulski, S. P. (2026). Actinomycetota-Derived Metabolites in Pancreatic Cancer: Chemical Diversity, Metabolic Vulnerability, and Translational Barriers. Current Oncology Reports. https://doi.org/10.1007/s11912-026-01842-y
Source records
- crossref · retrieved 2026-11-10T20:19:42.521Z